EMEA-001577-PIP02-14-M03

Key facts

Invented name
Descovy
Active substance
  • emtricitabine
  • tenofovir alafenamide
Therapeutic area
Infectious diseases
Decision number
P/0171/2018
PIP number
EMEA-001577-PIP02-14-M03
Pharmaceutical form(s)
  • Age-appropriate oral formulation
  • Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Gilead Sciences International Ltd

E-mail: regulatory.pip@gilead.com
Tel. +44 (0)1223 897300

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating